Drug Shortage Report for VINCRISTINE SULFATE INJECTION
| Report ID | 98179 |
| Drug Identification Number | 02143305 |
| Brand name | VINCRISTINE SULFATE INJECTION |
| Common or Proper name | VINCRISTINE INJECTION 1MG/ML |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | VINCRISTINE SULFATE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 5ML |
| ATC code | L01CA |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-11-06 |
| Estimated end date | 2020-02-29 |
| Actual end date | 2020-02-20 |
| Shortage status | Resolved |
| Updated date | 2020-02-21 |
| Company comments | We have 1 and 2ml. available as a substitute for the 5ml. |
| Health Canada comments | |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.